Sarcopenia affects activities of daily living recovery and hospitalization costs in older adults in convalescent rehabilitation wards

被引:10
作者
Yagi, Takuma [1 ]
Inoue, Tatsuro [2 ]
Ogawa, Masato [3 ]
Shimada, Yusuke [1 ]
Heguri, Yasunori [1 ]
Okada, Risa [1 ]
Iwata, Shuto [1 ]
Kishimoto, Mizuho [1 ]
机构
[1] Hattori Hosp, Dept Rehabil, 218-3 Otsuka, Miki City, Hyogo 6730413, Japan
[2] Niigata Univ Hlth & Welf, Dept Phys Therapy, Kita Ku, 1398 Shimami Cho, Niigata 9503198, Japan
[3] Kobe Univ, Dept Publ Hlth, Grad Sch Hlth Sci, Chuo Ku, 5-2 7 Chome Kusunokicho, Kobe, Hyogo 6500017, Japan
关键词
Convalescent rehabilitation; Costs; Functional recovery; Sarcopenia; Older adults; DISABILITY; MORTALITY; CONSENSUS; OBESITY; HEALTH;
D O I
10.1007/s41999-021-00552-x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Purpose This study aimed to investigate the impact of sarcopenia on activities of daily living (ADL) recovery and hospitalization costs in older patients admitted to convalescent rehabilitation wards. Methods This prospective cohort study included 104 patients aged >= 65 years who were admitted to convalescent rehabilitation wards. The primary outcome was ADL recovery as evaluated by the Functional Independence Measure (FIM) efficiency during hospitalization, and the secondary outcome was hospital-related costs. Univariate and multivariate analyses were performed to identify whether sarcopenia was associated with FIM-motor efficiency and hospitalization costs. Results Among the patients, 68.3% were females, and the mean age was 82.3 +/- 8.3 years. The prevalence of sarcopenia was 73.1%. The FIM-motor efficiency score was significantly lower in patients with sarcopenia (median 0.38; interquartile range 0.27-0.52) than in those without sarcopenia (median 0.55; interquartile range 0.34-0.87) (P = 0.009). Hospitalization costs were higher in patients with sarcopenia (32,813 +/- 15,184 dollars) than in those without sarcopenia (26,879 +/- 10,248 dollars) (P = 0.058). Multivariate analysis showed that sarcopenia was independently associated with FIM-motor efficiency (standardized beta = - 0.236, P = 0.014, R-2 = 0.40) and hospitalization costs (standardized beta = 0.15, P = 0.027, R-2 = 0.70) after adjusting for confounding factors. Conclusion We found that sarcopenia reduces the FIM-motor efficiency and increases direct hospitalization costs in older patients admitted to convalescent rehabilitation wards. Therefore, it is necessary to design interventions to prevent sarcopenia and improve the efficiency of ADL recovery and reduce direct hospitalization cost. Key summary pointsAim Our aim was to investigate the effect of sarcopenia on the rate of activities of daily living (ADL) recovery and hospitalization costs in older patients who were admitted to convalescent rehabilitation wards. Findings ADL recovery, evaluated by the Functional Independence Measure motor efficiency score, was significantly lower in patients with sarcopenia than in those without sarcopenia. Moreover, the hospitalization costs were higher in patients with sarcopenia than in those without sarcopenia. Message Implementation of appropriate interventions for sarcopenia may accelerate ADL recovery and decrease hospitalization costs.
引用
收藏
页码:1237 / 1245
页数:9
相关论文
共 30 条
  • [1] Prognostic value of a rapid sarcopenia measure in acutely ill older adults
    Aliberti, Marlon J. R.
    Szlejf, Claudia
    Covinsky, Kenneth E.
    Lee, Sei J.
    Jacob-Filho, Wilson
    Suemoto, Claudia K.
    [J]. CLINICAL NUTRITION, 2020, 39 (07) : 2114 - 2120
  • [2] Sarcopenia and hospitalisation costs in older adults: a cross-sectional study
    Antunes, Ana C.
    Araujo, Daniela A.
    Verissimo, Manuel T.
    Amaral, Teresa F.
    [J]. NUTRITION & DIETETICS, 2017, 74 (01) : 46 - 50
  • [3] Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
    Biolo, Gianni
    Cederholm, Tommy
    Muscaritoli, Maurizio
    [J]. CLINICAL NUTRITION, 2014, 33 (05) : 737 - 748
  • [4] Inpatient costs and blood transfusion rates of sarcopenic patients following thoracolumbar spine surgery
    Bokshan, Steven L.
    Han, Alex
    DePasse, J. Mason
    Marcaccio, Stephen E.
    Eltorai, Adam E. M.
    Daniels, Alan H.
    [J]. JOURNAL OF NEUROSURGERY-SPINE, 2017, 27 (06) : 676 - 680
  • [5] The health economics burden of sarcopenia: a systematic review
    Bruyere, Olivier
    Beaudart, Charlotte
    Ethgen, Olivier
    Reginster, Jean-Yves
    Locquet, Medea
    [J]. MATURITAS, 2019, 119 : 61 - 69
  • [6] Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code
    Cao, Li
    Morley, John E.
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (08) : 675 - 677
  • [7] Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
    Chen, Liang-Kung
    Woo, Jean
    Assantachai, Prasert
    Auyeung, Tung-Wai
    Chou, Ming-Yueh
    Iijima, Katsuya
    Jang, Hak Chul
    Kang, Lin
    Kim, Miji
    Kim, Sunyoung
    Kojima, Taro
    Kuzuya, Masafumi
    Lee, Jenny S. W.
    Lee, Sang Yoon
    Lee, Wei-Ju
    Lee, Yunhwan
    Liang, Chih-Kuang
    Lim, Jae-Young
    Lim, Wee Shiong
    Peng, Li-Ning
    Sugimoto, Ken
    Tanaka, Tomoki
    Won, Chang Won
    Yamada, Minoru
    Zhang, Teimei
    Akishita, Masahiro
    Arai, Hidenori
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (03) : 300 - +
  • [8] TT3, a More Practical Indicator for Evaluating the Relationship Between Sarcopenia and Thyroid Hormone in the Euthyroid Elderly Compared with FT3 [Letter]
    Sun, Jingxia
    Huang, Jianhao
    Lu, Wensheng
    [J]. CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1361 - 1362
  • [9] Sarcopenia: revised European consensus on definition and diagnosis
    Cruz-Jentoft, Alfonso J.
    Bahat, Gulistan
    Bauer, Juergen
    Boirie, Yves
    Bruyere, Olivier
    Cederholm, Tommy
    Cooper, Cyrus
    Landi, Francesco
    Rolland, Yves
    Sayer, Avan Aihie
    Schneider, Stephane M.
    Sieber, Cornel C.
    Topinkova, Eva
    Vandewoude, Maurits
    Visser, Marjolein
    Zamboni, Mauro
    [J]. AGE AND AGEING, 2019, 48 (01) : 16 - 31
  • [10] Sarcopenia: European consensus on definition and diagnosis
    Cruz-Jentoft, Alfonso J.
    Baeyens, Jean Pierre
    Bauer, Juergen M.
    Boirie, Yves
    Cederholm, Tommy
    Landi, Francesco
    Martin, Finbarr C.
    Michel, Jean-Pierre
    Rolland, Yves
    Schneider, Stephane M.
    Topinkova, Eva
    Vandewoude, Maurits
    Zamboni, Mauro
    [J]. AGE AND AGEING, 2010, 39 (04) : 412 - 423